Emergent BioSolutions Inc. (EBS)
Annual Shareholder Meeting Conference Call
May 17, 2012 9:00 am ET
Fuad El-Hibri – Executive Chairman
Jay G. Reilly – General Counsel
Daniel J. Abdun-Nabi – President and Chief Executive Officer
Good morning ladies and gentlemen, the 2012 Annual Meeting of Stockholders of Emergent BioSolutions is hereby called to order. I’m Fuad El-Hibri, Executive Chairman of the Board of Emergent BioSolutions. I’m pleased to welcome you to our 2012 Annual Meeting of Stockholders. Following the conclusion of this meeting Dan Abdun-Nabi, our Chief Executive Officer, will provide you with a brief update on the current status of the company.
When you sign in this morning, you should have received a registration packet that includes an agenda and rules of conduct. We’ll conduct this annual meeting in accordance with that agenda and those rules. If you wish to ask a question or speak about a matter of being voted on today, I’ll call for questions on those matters at an appropriate point in the meeting. If you wish to speak about a matter not being voted on today, please wait until I call for questions and comments after the formal meeting.
In attendance today are members of our Board of Directors, as I call your name please stand up, Dan Abdun-Nabi, who is also our President and Chief Executive Officer, Dr. Lu Sullivan, Chair of our Compensation Committee, Dr. Zsolt Harsanyi, Dr. Sue Bailey, Chair of our Scientific Review Committee, Marvin White, Chair of our Audit Committee, Dr. John Niederhuber, and Ron Richard, Chair of our Nominating and Corporate Governance Committee and our Lead Independent Director. The Inspector of election has taken the oath of office, which will be filed with the minutes of this meeting.